Breast cancer in Mexico: A growing challenge to health and the health system

The Lancet Oncology

Volumn 13, Issue 8, 2012, Pages

  Chávarri Guerra, Yanin ^a,b,d   Villarreal Garza, Cynthia ^c   Liedke, Pedro ER ^a,d   Knaul, Felicia ^d,e,f,g   Mohar, Alejandro ^c,h   Finkelstein, Dianne M ^a   Goss, Paul E ^a,d  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HARVARD UNIVERSITY   (United States)

^f Mexican Foundation for Health   (Mexico)

^g Tómatelo a Pecho Mexican Health Foundation FUNSALUD   (Mexico)

^h UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; OPIATE; PACLITAXEL; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADVANCED CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RESEARCH; CANCER RISK; CANCER SCREENING; CANCER STATISTICS; CANCER THERAPY; DEMOGRAPHY; DEVELOPING COUNTRY; DISEASE FREE SURVIVAL; DRUG LEGISLATION; EARLY DIAGNOSIS; FINANCIAL MANAGEMENT; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; INFORMATION DISSEMINATION; MAMMOGRAPHY; MASTECTOMY; MEDICAL CARE; MEDICAL EDUCATION; MEDICAL INFORMATION; MEXICO; MULTIPLE CYCLE TREATMENT; PARTIAL MASTECTOMY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SOCIAL SECURITY; SOUTH AND CENTRAL AMERICA; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; DELIVERY OF HEALTH CARE, INTEGRATED; EARLY DETECTION OF CANCER; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES ACCESSIBILITY; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MEXICO; MIDDLE AGED; PREVENTIVE HEALTH SERVICES; PROGNOSIS; QUALITY OF HEALTH CARE; RISK ASSESSMENT; RISK FACTORS; WOMEN'S HEALTH SERVICES;

EID: 84864366243     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70246-2     Document Type: Review

References (79)

1. Cancer: fact sheet number 297 WHO, (accessed Jan 3, 2012). http://www.who.int/mediacentre/factsheets/fs297/en/index.html.
2. Farmer P, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010, 376:1186-1193.
3. Knaul FM, Frenk J, Shulman L, et al. Closing the cancer divide: a blueprint to expand access in low and middle income countries for the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, (accessed Jan 20, 2012). http://ghsm.hms.harvard.edu/uploads/pdf/ccd_report_111027.pdf.
4. GLOBOCAN 2008: cancer incidence and mortality worldwide in 2008 International Agency for Research on Cancer, WHO, (accessed Jan 3, 2012). http://globocan.iarc.fr/.
5. Forouzanfar MH, Foreman KJ, Delossantos AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 2011, 378:1461-1484.
6. Palacio-Mejia LS, Lazcano-Ponce E, Allen-Leigh B, Hernández-Avila M Regional differences in breast and cervical cáncer mortality in Mexico between 1979-2006. Salud Publica Mex 2009, 51(suppl 2):s208-s219. in Spanish).
7. The indigenous population in Mexico Instituto Nacional de Estadística y Geografía (INEGI), (accessed Jan 3, 2012 [in Spanish]). http://www.inegi.org.mx/prod_serv/contenidos/espanol/bvinegi/productos/censos/poblacion/poblacion_indigena/Pob_ind_Mex.pdf.
8. Statistics about the world day against cancer national data INEGI, (accessed Feb 3, 2012 [in Spanish]). http://www.inegi.org.mx/inegi/contenidos/espanol/prensa/aProposito.asp?s=inegi&ep=50&c=2780.
9. Knaul FM, Nigenda G, Lozano R, Arreola-Ornelas H, Langer A, Frenk J Breast cancer in Mexico: a pressing priority. Reprod Health Matters 2008, 16:113-123.
10. Anderson BO, Cazap E, El Saghir NS, et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol 2011, 12:387-398.
11. Lee BL, Liedke PER, Barrios CH, et al. Breast cancer in Brazil: present status and future goals. Lancet Oncol 2012, 13:e95-102.
12. Sistema Nacional de Informacion en Salud, (accessed Jan 4, 2012 [in Spanish]). http://sinais.salud.gob.mx/.
13. Instituto Nacional de Estadistica y Geografia, (accessed Jan 4, 2012 [in Spanish]). http://www.inegi.org.mx/.
14. Census of population and housing counts, 2010 INEGI, (accessed Jan 4, 2012 [in Spanish]). http://www.inegi.org.mx/est/contenidos/Proyectos/ccpv/default.aspx.
15. Joinpoint regression program (version 3.5.1) National Cancer Institute, (accessed Jul 7, 2011). http://surveillance.cancer.gov/joinpoint/.
16. Annual morbidity 1984-2010 Centro Nacional de Vigilancia Epidemiologica y Control de Enfermedades, (accessed Jan 4, 2012 [in Spanish]). http://www.dgepi.salud.gob.mx/anuario/.
17. Mexico Histopathologic Cancer Registry, (accessed May 8, 2011). http://www.dgepi.salud.gob.mx/diveent/RHNM.htm.
18. Franci-Marina F, Lazcano Ponce E, Lopez Carrillo L Breast cancer mortality in Mexico. An age-period-cohort analysis. Salud Publica Mex 2009, 51:s157-s164.
19. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005, 353:1784-1792.
20. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2009, 151:716-726. US Preventive Services Task Force.
21. Annual mammograms now recommended for women beginning at age 40 American Congress of Obstetricians and Gynecologists, (accessed April 3, 2011). http://www.acog.org/from_home/publications/press_release/nr07-20-11-2.cfm.
22. Standard NOM-041-SSA2-2011, for the prevention, diagnosis, treatment, control and surveillance epidemiology of breast cancer (accessed Jan 25, 2012). http://dof.gob.mx/nota_detalle.php?codigo=5194157&fecha=09/06/2011.
23. Breast cancer: specific action program 2007-2012 Secretaria de Salud, (accessed Jan 19, 2012 [in Spanish]). http://www.cnegsr.gob.mx/programas/cancer-mama/interes-mama/pa-mama.html.
24. Martinez-Montanez OG, Uribe-Zuniga P, Hernandez Avila M Public policies for the detection of breast cancer in Mexico. Salud Publica Mex 2009, 51:S350-S360.
25. Baseline medical survey on medical devices 2010 WHO, (accessed Jan 19, 2012). http://whqlibdoc.who.int/hq/2011/WHO_HSS_EHT_DIM_11.01_eng.pdf.
26. Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy T, et al. National survey of health and nutrition 2006. Instituto Nacional de Salud Pública (accessed July 20, 2011 [in Spanish]). http://insp.mx/ensanut/ensanut2006.pdf.
27. Sosa-Rubí SG, Walker D, Serván E Performance of mammography and Papanicolau among rural women in Mexico. Salud Publica Mex 2009, 51(suppl 2):s236-s245. (in Spanish).
28. Liao Y, Bang D, Cosgrove S, et al. Surveillance of health status in minority communities-racial and ethnic approaches to community health across the US (REACH US) risk factor survey, United States, 2009. MMWR Surveill Summ 2011, 60:1-44.
29. Assessment of public health activities Department of Health, Mexico, (accessed Jan 4, 2012 [in Spanish]). http://www.dged.salud.gob.mx/contenidos/dess/saludpublica.html.
30. Valencia-Mendoza A, Sanchez-Gonzalez G, Bautista-Arredondo S, Torres-Mejia G, Bertozzi SM Cost-effectiveness of breast cancer screening policies in Mexico. Salud Publica Mex 2009, 51:s296-s304.
31. Knaul FM, Arreola-Ornelas H, Velazquez E, Dorantes J, Mendez O, Avila-Burgos L The health care costs of breast cancer: the case of the Mexican Social Security Institute. Salud Publica Mex 2009, 51:s286-s295.
32. Villarreal-Garza C, Garcia-Aceituno L, Villa AR, Perfecto-Arroyo M, Rojas-Flores M, Leon-Rodriguez E Knowledge about cancer screening among medical students and internal medicine resident in Mexico City. J Canc Educ 2010, 25:624-631.
33. Ortiz Mendoza CM, Galvan Martinez EA Reproductive risk factors for breast cancer patients treated at an urban hospital in second level. Ginecol Obstet Mex 2007, 75:11-16. (in Spanish).
34. Tovar-Guzman V, Hernandez-Giron C, Lazcano-Ponce E, Romieu I, Hernandez Avila M Breast cancer in Mexican women: an epidemiological study with cervical cancer control. Salud Publica Mex 2000, 34:112-119.
35. Romieu I, Hernandez-Avila M, Lazcano E, Lopez L, Romero-Jaime R Breast cancer and lactation history in Mexican women. Am J Epidemiol 1996, 143:543-552.
36. Lopez-Carrillo L, Bravo-Alvarado J, Poblano-Verastegui O, Ortega Altamirano D Reproductive determinants of breast cancer in Mexican Women. Ann NY Acad Sci 1997, 837:537-550.
37. Sánchez-Zamorano LM, Flores-Luna L, Angeles-Llerenas A Healthy lifestyle on the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2011, 20:912-922.
38. Franco-Marina F, Lozano R, Villa B, Soliz P. Mortality in Mexico, 2000-2004: preventable deaths: extent, distribution and trends. Mexico, DF: Secretaria de Salud, 2006 (in Spanish).
39. Ortiz-Rodriguez SP, Torres-Mejia G, Mainero-Ratchelous F, et al. Physical activity and breast cancer risk in Mexican women. Salud Publica Mex 2008, 50:126-135.
40. Torres-Sanchez L, Galvan-Portillo M, Lewis S, Gomez-Dantes H, Lopez-Carrillo L Diet and breast cancer in Latin-America. Salud Publica Mex 2009, 51(suppl 2):s181-s190.
41. Lara-Medina F, Perez-Sanchez V, Saavedra-Perez D, et al. Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity. Cancer 2011, 117:3658-3669.
42. Narod SA Screening for BRCA1 and BRCA2 mutations in breast cancer patients from Mexico: the public health perspective. Salud Publica Mex 2009, 51:s191-s196.
43. Calderon-Garciduenas AL, Ruiz-Flores P, Cerda-Flores RM, Barrera-Saldana HA Clinical follow up of Mexican women with early onset of breast cancer and mutations in the BRCA1 and BRCA2 genes. Salud Publica Mex 2005, 47:110-115.
44. Fejerman L, Romieu I, John EM, et al. European ancestry associated with breast cancer risk in Mexican women. Cancer Epidemiol Biomarkers Prev; 19: 1074-82.
45. Medina-Franco H, Garza E, Gabilondo B, Gaona-Luviano P Risk of invasive breast cancer in Mexican population and patterns of screening and prophylaxis. Rev Invest Clin 2004, 56:422-426.
46. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998, 90:1371-1388.
47. Goss PE, Ingle JN, Ales-Martinez J, et al. Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med 2011, 364:2381-2391.
48. Sánchez JC, Valle AE, Molina EM, Chacón AP Fourth revision of the National Consensus on Diagnosis and Treatment of breast Cancer (accessed June 27, 2012). http://consensocancermamario.com/lib/files/documents/uploaded/CONSENSO_CANCER_DE_MAMA_FINAL_11_DE_OCTUBRE.pdf.
49. Shulman LN, Willett W, Sievers A, Knaul FM Breast cancer in developing countries: opportunities for improved survival. J Oncol 2010, 2010:595167.
50. Lopez-Carrillo L, Torres-Sanchez L, Lopez-Cervantes M, Rueda-Neria C Identification of malignant breast lesions in Mexico. Salud Publica Mex 2001, 43:199-202.
51. Mohar A, Bargallo E, Ramirez MT, Lara F, Beltran-Ortega A Available resources for the treatment of breast cancer in Mexico. Salud Publica Mex 2009, 51:s263-s269.
52. SEER cancer statistics review, 1975-2008 National Cancer Institute, (accessed Jan 25, 2012). http://seer.cancer.gov/csr/1975_2008/.
53. Nigenda G, Caballero M, González-Robledo LM Access barriers in early diagnosis of breast cancer in the Federal District and Oaxaca. Salud Publica Mex 2009, 51(suppl 2):s254-s262. (in Spanish).
54. Bright K, Barghash M, Donach M, Gutierez de la Barrera M, Schneider RJ, Formenti SC The role of health system factors in delaying final diagnosis and treatment of breast cancer in Mexico City, Mexico. Breast 2011, 20:s54-s59.
55. Unger-Saldana K, Infante-Castaneda C Delay of medical care for symptomatic breast cancer: a literature review. Salud Publica Mex 2009, 51:s270-s285.
56. Rodriguez-Cuevas S, Macias CG, Franceschi D, Labastida S Breast carcinoma presents a decade earlier in Mexican women than in women in the United States or European countries. Cancer 2001, 91:863-868.
57. Kouri EM, He Y, Winer EP, Keating NL Influence of birthplace on breast cancer diagnosis and treatment for Hispanic women. Breast Cancer Res Treat 2010, 121:743-751.
58. Arce-Salinas C, Ulises Lara F, Alvarado-Miranda A, et al. Evaluation of treatment of breast cancer in a tertiary level with the Seguro Popular, Mexico. Rev Invest Clin 2012, 64:9-16. (in Spanish).
59. Willems SM, van Deurzen CHM, van Diest PJ Diagnosis of breast lesions: fine-needle aspiration cytology or core needle biopsy? A review. J Clin Pathol 2012, 65:287-292.
60. Medina-Franco H, Abarca-Perez L, Cortes-Gonzalez R, Soto-Germes S, Ulloa JA, Uribe N Fine needle aspiration biopsy of breast lesions: institutional experience. Rev Invest Clin 2005, 57:394-398.
61. Carrillo JF, Mendivil MF, Dominguez JR, de Obaldia GE, Esparza R Accuracy of combined clinical findings and fine needle aspiration cytology for the diagnosis in palpable breast tumors. Rev Invest Clin 1999, 51:333-339.
62. Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol 2008, 26:1275-1281.
63. Patel TA, Colon-Otero G, Bueno Hume C, et al. Breast cancer in Latinas: gene expression, differential response to treatments, and differential toxicities in Latinas compared with other population groups. Oncologist 2010, 15:466-475.
64. Bargallo-Rocha JE, Lara F, Shawn Dulin RJ, et al. A study of impact of the 21-gene breast cancer assay on the use of adjuvant chemotherapy in women with breast cancer in a Mexican public hospital. ESMO 2012-37th European Society for Medical Oncology Congress; Vienna, Austria; Sept 28-Oct 2, 2012. 2126.
65. Gomez Dantes O, Sesma S, Becerril VM, Knaul FM, Arreola H, Frenk J The health system of Mexico. Salud Publica Mex 2011, 53:S220-S232. (in Spanish).
66. Government and Society. Summary table: socioeconomic indicators National Institute of Statistics, Geography, and Informatics, (accessed June 27, 2012). http://www.inegi.org.mx/sistemas/temasV2/Default.aspx?s=est&c=21702.
67. Jatoi I, Proschan MA Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer. A pooled analysis of updated results. Am J Clin Oncol 2005, 28:289-294.
68. Habermann EB, Abbott A, Parsons HM, Virnig BA, Al-Refaie WB, Tuttle TM Are mastectomy rates really increasing in the United States?. J Clin Oncol 2010, 28:3437-3441.
69. Meric F, Mirza NQ, Vlastos G, et al. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 2003, 97:926-933.
70. Veronesi U, Viale G, Paganelli G, et al. Sentinel lymph node biopsy in breast cancer. ten-year results of a randomized controlled study. Ann Surg 2010, 251:595-600.
71. Vergara-Fernandez O, Cortes-Gonzalez R, Medina-Franco H Validation of sentinel node in breast cancer. Rev Invest Clin 2004, 56:309-313.
72. Gallegos-Hernandez JF, Chavez-Garcia MA, Najera I, Ramirez-Ramirez L, Duran-Martinez M Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. Gac Med Mex 2003, 139:205-208.
73. Zarco Espinosa G, Barroso Bravo S, Ochoa Carrillo FJ, et al. Recommendations in metastatic breast cancer. GAMO 2009, 8(suppl 2):1-16.
74. Torres Vigil I, Aday LA, De Lima L, Cleeland CS What predicts the quality of advanced cancer care in Latin America? A look at five countries: Argentina, Brazil, Cuba, Mexico and Peru. J Pain Symptom Manage 2007, 34:315-327.
75. Cazap E, Buzaid AC, Garbino C, et al. Breast cancer in Latin America. Results of the Latin American and Caribbean Society of Medical Oncology/Breast Cancer Research Foundation Expert Survey. Cancer 2008, 113:2359-2365.
76. Chavarri-Guerra Y, Liedke PER, Symecko H, et al. 34th Annual San Antonio Breast Cancer Symposium (SABCS); San Antonio, Texas; Dec 6-10, 2011. P1-11-12.
77. 2012 (accessed Jan 25, 2012). http://www.clinicaltrials.gov.
78. Maza-Fernandez ME, Vecchi-Martini E History, overview and challenges of the breast cancer movement in Mexico. Salud Publica Mex 2009, 51:s329-s334.
79. Knaul FM, López Carrillo L, Maza Fernández ME, et al. Rosa Mexico report 2009-2010: breast cancer-CON-science (accessed Jan 4, 2012). http://www.tomateloapecho.org.mx/Archivos%20web%20TAP/Presentacion%20Reporte%20Rosa/REPORTE%20ROSA%202009-2010.pdf.